Sun Pharma Receives EIR for Halol Facility
Sun Pharmaceutical Industries Ltd. has announced that it has received the Establishment Inspection Report (EIR) from the US FDA for the inspection conducted at its Halol facility (Gujarat) during the period February 12-23, 2018. The agency concluded that the inspection is now closed and the issues contained in the Warning Letter issued in December 2015 have been addressed. “This is an important development for Sun Pharma. We remain committed to following the highest levels of quality and 24x7 cGMP compliance at all our manufacturing facilities globally,” Mr. Dilip Shanghvi, Managing Director, Sun Pharma said on the development.
Dilip Shanghvi
You May Interested In
Glow70/KLOW80 99% China Peptides Warehouse Direct Delivery Lyophilized Powder in Stock
$169/UNIT FOB
2026-10-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Red Sun: The company is committed to supply 97% Chlorantraniliprole technical no less than 1000 tons to Sino-Agri this year
-
China丨The first phase of Red Sun's digital transformation project launched
-
Sun Pharma announces licensing agreement with CSIR-IICT
-
AkzoNobel Rejects €12.5 Billion Offer from Nippon Paint and Sherwin-Williams, Sticks to Merger with Axalta
-
Dow Swings from an $801 Million Loss to an $802 Million Profit as Hormuz Disruption Lifts Polyethylene Prices
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
-
Argentina to Build Latin America’s Largest Urea Plant Under €1.3 Billion Contract
-
RMB 240 Million! Wanhua Chemical Establishes Another Joint Venture in Binzhou
-
Wanhua Chemical's 240,000-ton/year Iron Phosphate Project Approved
-
Pharmaceutical State-Owned Enterprise Acquires Leading Pesticide Company for RMB 5.656 Billion, Betting on Synthetic Biology Industrialization
Recommend Reading
-
![Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency]()
Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency
-
![Wanhua’s Counter-Cyclical Expansion: A Gamble or a Strategic Move for the Next Cycle?]()
Wanhua’s Counter-Cyclical Expansion: A Gamble or a Strategic Move for the Next Cycle?
-
![A Comprehensive Overview of China’s Special Engineering Materials Market: How Should the Industry Rebuild Its Capabilities Amid Growing Downstream Pressure?]()
A Comprehensive Overview of China’s Special Engineering Materials Market: How Should the Industry Rebuild Its Capabilities Amid Growing Downstream Pressure?
-
![Zydus Brings the First Keytruda Biosimilar Showdown to North America]()
Zydus Brings the First Keytruda Biosimilar Showdown to North America
-
![Asahi Kasei Draws the Line on HMD: Strategic Exit from Hexamethylenediamine Production Signals Portfolio Refocus]()
Asahi Kasei Draws the Line on HMD: Strategic Exit from Hexamethylenediamine Production Signals Portfolio Refocus
-
![Business Society September 22, 2026 Cyclohexanone Trend Analysis: Volatile and Bearish]()
Business Society September 22, 2026 Cyclohexanone Trend Analysis: Volatile and Bearish
-
![Business Society September 22, 2026 Styrene Trend Analysis: High-Level Volatility]()
Business Society September 22, 2026 Styrene Trend Analysis: High-Level Volatility
-
![Business Society September 21, 2026 Hydrofluoric Acid Trend Analysis: Volatility]()
Business Society September 21, 2026 Hydrofluoric Acid Trend Analysis: Volatility
-
![Business Society DOP Trend Analysis, September 22, 2026: Clear Decline]()
Business Society DOP Trend Analysis, September 22, 2026: Clear Decline
-
![Business Society September 21, 2026 Maleic Anhydride Trend Analysis: Volatility]()
Business Society September 21, 2026 Maleic Anhydride Trend Analysis: Volatility
